Management of Constipation
For the management of constipation, polyethylene glycol (PEG) is strongly recommended as the first-line pharmacological treatment due to its excellent efficacy and safety profile. 1
Assessment and Diagnosis
Before initiating treatment, proper assessment is crucial:
- Evaluate for underlying causes including medications, metabolic disorders, and mechanical obstruction 2
- Perform physical examination including abdominal examination, perineal inspection, and digital rectal examination 2
- Consider plain abdominal X-ray in severe cases to assess fecal loading and exclude bowel obstruction 1
- Rule out impaction, especially if diarrhea accompanies constipation 2
Treatment Algorithm
Step 1: Non-pharmacological Approaches
- Ensure privacy and comfort for normal defecation 1
- Optimize positioning (use a small footstool to assist with defecation) 1
- Increase fluid intake 1
- Encourage physical activity within patient limits 1
- Gradually increase dietary fiber to 20-25g per day, focusing on soluble fiber sources 2
Step 2: First-line Pharmacological Treatment
- Polyethylene glycol (PEG) - strongly recommended due to excellent efficacy and safety profile 1
Step 3: Alternative or Add-on Treatments
Based on response and patient characteristics:
Stimulant laxatives - strong recommendation for sodium picosulfate; conditional recommendation for senna 1
- Particularly useful for short-term rescue therapy (bisacodyl 5-10mg daily) 2
Osmotic laxatives - conditional recommendation for lactulose and magnesium oxide 1
Fiber supplements - conditional recommendation 1
Step 4: Advanced Pharmacological Options
For refractory constipation:
- Secretagogues - strong recommendation for linaclotide and plecanatide 1
- Serotonin type 4 agonist - strong recommendation for prucalopride 1
- Lubiprostone - conditional recommendation 1
Step 5: For Opioid-induced Constipation
- Start prophylactic stimulant laxative plus stool softener 2
- Increase laxative dose when increasing opioid dose 2
- For refractory cases, consider peripherally acting mu-opioid receptor antagonists (methylnaltrexone, naloxegol, naldemedine) 2
Special Considerations
For Severe Constipation/Impaction
- Manual disimpaction following pre-medication with analgesic/anxiolytic 2
- Glycerine suppository or mineral oil retention enema 2
- Tap water enema until clear for severe cases 2
Contraindications and Precautions
- Docusate has not shown benefit and is not recommended 2
- Supplemental medicinal fiber may worsen constipation in many cases 2
- Limit sodium phosphate laxatives in patients at risk for renal dysfunction 2
- Peripherally acting mu-opioid receptor antagonists should not be used with suspected mechanical bowel obstruction 2
For Defecatory Disorders
- Biofeedback therapy improves symptoms in >70% of patients and should be considered before laxatives 2
Monitoring and Follow-up
- Schedule follow-up within 2-4 weeks of initiating treatment 2
- Monitor frequency and consistency of bowel movements, abdominal pain, and medication compliance 2
- Adjust treatment based on response 2
- For chronic constipation, gradually taper medication once a regular bowel pattern is established 2
Common Pitfalls to Avoid
- Relying solely on lifestyle modifications without appropriate pharmacological intervention 1, 2
- Using fiber supplements in patients with severe constipation or suspected obstruction 2
- Continuing ineffective treatments without reassessment 2
- Failing to prophylactically treat constipation when prescribing opioids 2
- Using peripherally acting mu-opioid receptor antagonists as first-line treatment 2
By following this structured approach to constipation management, clinicians can effectively address this common condition while minimizing complications and improving patient quality of life.